Home › Funds › ORBIMED ADVISORS LLC › HUM
ORBIMED ADVISORS LLC position in HUM
HUMANA INC · Health Care
ORBIMED ADVISORS LLC reported holding 164,100 shares of HUM (HUMANA INC) in its Q2 2026 13F filing — a position valued at US$65.2M, representing 1.31% of its reported portfolio and ranking #22 among its reported holdings. ORBIMED ADVISORS LLC has disclosed HUM holdings in 3 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ORBIMED ADVISORS LLC's HUM position evolved
ORBIMED ADVISORS LLC first disclosed a stake in HUM in Q3 2023 at 342,500 shares (US$166.6M). Across 3 filings, ORBIMED ADVISORS LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 164,100 shares valued at US$65.2M. Notable position changes include a 68% trim in Q4 2023 (shares fell 24% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 342.50K | $166.63M | New |
| Q4 2023 | 109.90K | $50.31M | Reduce |
| Q2 2026 | 164.10K | $65.18M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About HUM and 13F data
HUM (HUMANA INC) is a Health Care company. 33 other funds we track also report a position in HUM — the largest reported positions include Dodge & Cox (US$4.35B), DODGE & COX (US$4.35B), Pzena Investment Management (US$1.75B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HUM
- Dodge & Cox 10.94M sh · $4.35B · Q2 2026
- DODGE & COX 10.94M sh · $4.35B · Q2 2026
- Pzena Investment Management 4.40M sh · $1.75B · Q2 2026
- MFS Investment Management 3.58M sh · $1.66B · Q2 2026
- EAGLE CAPITAL MANAGEMENT LLC 3.85M sh · $1.53B · Q2 2026
- Sessa Capital IM, L.P. 3.73M sh · $1.48B · Q2 2026
- NAYA CAPITAL MANAGEMENT UK LTD 1.83M sh · $728.41M · Q2 2026
- Assenagon Asset Management S.A. 1.26M sh · $479.05M · Q3 2026
- Slate Path Capital LP 1.08M sh · $428.97M · Q2 2026
- Newport Trust Company, LLC 968.65K sh · $384.77M · Q2 2026
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 878.38K sh · $348.91M · Q2 2026
More on ORBIMED ADVISORS LLC
FAQ
How long has ORBIMED ADVISORS LLC held HUM?
ORBIMED ADVISORS LLC has disclosed HUM holdings in 3 of the last 12 reported quarters, going back to Q3 2023.
What is ORBIMED ADVISORS LLC's current position in HUM?
As of Q2 2026, ORBIMED ADVISORS LLC holds 164.10K shares of HUM (HUMANA INC), valued at $65.18M, representing 1.31% of its reported portfolio and ranking #22.
Has ORBIMED ADVISORS LLC been buying or selling HUM?
In the latest 13F filing (Q2 2026), ORBIMED ADVISORS LLC newly opened its position in HUM.
Which other funds hold HUM?
Other major institutional holders of HUM include Dodge & Cox, DODGE & COX, Pzena Investment Management, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.